Foreign institutional investors (FIIs) remained net sellers in Indian equities on Friday, offloading shares worth a provisional ₹3,892.77 crore, while domestic institutional investors (DIIs) continued to offset the selling with net purchases of ₹5,453.55 crore.
Shares of Lodha Developers Limited ended at ₹1,144.10, down by ₹2.50, or 0.22%, on the BSE.
Shares of 3M India Ltd ended at ₹35,456.00, down by ₹215.75, or 0.61%, on the BSE.
Swiggy CEO Sriharsha Majety’s reported remuneration surged to ₹551.2 crore in FY26 after exercising employee stock options worth ₹549.3 crore. His actual cash salary and incentive stood at ₹1.9 crore, while the rest reflected the taxable value of ESOPs exercised…
Shares of Container Corporation of India Ltd ended at ₹477.80, down by ₹2.90, or 0.60%, on the BSE.
US stock futures rose on Friday, with Dow futures gaining more than 200 points as oil prices retreated from recent highs, helping improve investor sentiment after a broad market selloff.
SEBI bans 21 entities in Axis Mutual Fund front-running case, disgorges over ₹30.55 crore, imposes ₹7.40 crore in penalties.
India’s listed mutual fund companies reported a strong June quarter, with higher profits helped by a rebound in equity markets. But a closer look shows that much of the earnings boost came from gains on their investment portfolios rather than…
Nandan Kulkarni, Director-India Healthcare at Bernstein believes higher drug prices, supply shortages and a gradual shift in manufacturing to the US could benefit players like Sun Pharma, Lupin and Zydus over the long term. Kulkarni also explains why innovation-led companies…
Indian pharma remains a long-term opportunity despite US tariff concerns, says Srinivas Rao Ravuri, Chief Investment Officer at Bajaj Life Insurance. He prefers contract manufacturers over generic drugmakers, backs the quick commerce leader despite rich valuations, and sees tactical opportunities…